BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17135187)

  • 21. Mapping the dimer interface in the C-terminal domains of the yeast MLH1-PMS1 heterodimer.
    Cutalo JM; Darden TA; Kunkel TA; Tomer KB
    Biochemistry; 2006 Dec; 45(51):15458-67. PubMed ID: 17176067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.
    Brieger A; Adam R; Passmann S; Plotz G; Zeuzem S; Trojan J
    Genes Chromosomes Cancer; 2011 Feb; 50(2):59-70. PubMed ID: 21064154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional studies on the candidate ATPase domains of Saccharomyces cerevisiae MutLalpha.
    Tran PT; Liskay RM
    Mol Cell Biol; 2000 Sep; 20(17):6390-8. PubMed ID: 10938116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.
    Srivatsan A; Bowen N; Kolodner RD
    J Biol Chem; 2014 Mar; 289(13):9352-64. PubMed ID: 24550389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saccharomyces cerevisiae MutLalpha is a mismatch repair endonuclease.
    Kadyrov FA; Holmes SF; Arana ME; Lukianova OA; O'Donnell M; Kunkel TA; Modrich P
    J Biol Chem; 2007 Dec; 282(51):37181-90. PubMed ID: 17951253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
    Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
    Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unstructured linker arms of Mlh1-Pms1 are important for interactions with DNA during mismatch repair.
    Plys AJ; Rogacheva MV; Greene EC; Alani E
    J Mol Biol; 2012 Sep; 422(2):192-203. PubMed ID: 22659005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
    Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
    Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations within the hMLH1 and hPMS2 subunits of the human MutLalpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSalpha.
    Räschle M; Dufner P; Marra G; Jiricny J
    J Biol Chem; 2002 Jun; 277(24):21810-20. PubMed ID: 11948175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of microRNA processing by mismatch repair protein MutLα.
    Mao G; Lee S; Ortega J; Gu L; Li GM
    Cell Res; 2012 Jun; 22(6):973-85. PubMed ID: 22290424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair.
    DuPrie ML; Palacio T; Calil FA; Kolodner RD; Putnam CD
    DNA Repair (Amst); 2022 Nov; 119():103405. PubMed ID: 36122480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of proliferating cell nuclear antigen with PMS2 is required for MutLα activation and function in mismatch repair.
    Genschel J; Kadyrova LY; Iyer RR; Dahal BK; Kadyrov FA; Modrich P
    Proc Natl Acad Sci U S A; 2017 May; 114(19):4930-4935. PubMed ID: 28439008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma.
    Jessri M; Dalley AJ; Farah CS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):74-82. PubMed ID: 25446502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Homologs of MutS and MutL during mammalian meiosis].
    Santucci-Darmanin S; Paquis-Flucklinger V
    Med Sci (Paris); 2003 Jan; 19(1):85-91. PubMed ID: 12836196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential ATP binding and intrinsic ATP hydrolysis by amino-terminal domains of the yeast Mlh1 and Pms1 proteins.
    Hall MC; Shcherbakova PV; Kunkel TA
    J Biol Chem; 2002 Feb; 277(5):3673-9. PubMed ID: 11717305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC6 regulates DNA damage response via deacetylating MLH1.
    Zhang M; Hu C; Moses N; Haakenson J; Xiang S; Quan D; Fang B; Yang Z; Bai W; Bepler G; Li GM; Zhang XM
    J Biol Chem; 2019 Apr; 294(15):5813-5826. PubMed ID: 30770470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
    Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
    Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
    Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
    BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome.
    Kratz CP; Holter S; Etzler J; Lauten M; Pollett A; Niemeyer CM; Gallinger S; Wimmer K
    J Med Genet; 2009 Jun; 46(6):418-20. PubMed ID: 19293170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.